reviewPharmacology & TherapeuticsNov 14, 2007Closed access

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

DEDaniel E. TraceyLKLars KlareskogEHEric H. SassoJSJochen SalfeldPPPaul P. Tak

Abbott (United States) · Karolinska University Hospital · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,614
total citations
FWCI
56.14
Percentile
100%
References
352
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Golimumab
  • Adalimumab
  • Etanercept
  • Infliximab
  • Tumor necrosis factor alpha
  • Immunology
  • Medicine
  • Psoriasis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.